Reza Zadno - 17 Sep 2021 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role
President, CEO, Director
Signature
/s/ Alaleh Nouri, Attorney-in-Fact for Reza Zadno, MD
Issuer symbol
PRCT
Transactions as of
17 Sep 2021
Transactions value $
$0
Form type
4
Filing time
21 Sep 2021, 18:35:21 UTC
Previous filing
14 Sep 2021
Next filing
04 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRCT Common Stock Conversion of derivative security +3.39K +6.45% 56K 17 Sep 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRCT Series F Convertible Preferred Stock Conversion of derivative security -3.39K -100% 0 17 Sep 2021 Common Stock 3.39K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock will convert automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date.